Imarx Therapeutics, Inc.

Tucson, AZ 85719

SBIR Award Summary

Total Number of Awards 11
Total Value of Awards $1.84MM
First Award Date 09/30/93
Most Recent Award Date 09/01/07

Key Personnel

Last Name Name Awards Contact
Matsunaga Terry Onichi Matsunaga 6
Wu Qiu Wu 2
Ramaswami Rajan Ramaswami 1
Zutshi Reena Zutshi 1
Unger Evan Charles Unger 1

11 Awards Won

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-06-21
Budget: 09/01/07 - 08/31/08

DESCRIPTION (provided by applicant): Ultrasound mediated destruction (UMD) of intravenously injected microbubbles has the potential to alter blood brain barrier (BBB) permeability at selective locations within the central nervous system. This selective alteration in BBB permeability could have significant therapeutic potential in targeting drug ...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/07 - 11/15/09

DESCRIPTION (provided by applicant): The long-term objective of this Phase II SBIR proposal is to develop targeted microbubbles in conjunction with ultrasound for the treatment of vascular thrombosis (Sonothrombolysis). Gas-filled microbubbles are currently used as vascular ultrasound diagnostic agents because of their exquisite ability to refle...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/01/06 - 06/30/07

DESCRIPTION (provided by applicant): The long-term objective of this Phase II SBIR proposal is to develop targeted microbubbles in conjunction with ultrasound for the treatment of vascular thrombosis (Sonothrombolysis). Gas-filled microbubbles are currently used as vascular ultrasound diagnostic agents because of their exquisite ability to refle...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/06/05 - 06/30/06

DESCRIPTION (provided by applicant): The long-term objective of this Phase II SBIR proposal is to develop targeted microbubbles in conjunction with ultrasound for the treatment of vascular thrombosis (Sonothrombolysis). Gas-filled microbubbles are currently used as vascular ultrasound diagnostic agents because of their exquisite ability to refle...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/15/02 - 08/14/04

DESCRIPTION (provided by applicant): Heart attacks and strokes account for 3.4 million deaths annually in the United States. Moreover, the morbidity from vascular disease accounts for billions of healthcare dollars as well. The basis for these vascular diseases generally involves the formation of occlusive clots in the vasculature, leading to lo...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/22/02 - 04/30/04

The project focuses on development of a nanoparticulate delivery system for therapeutic agents which are difficult to solubilize in aqueous media. The formulations are particularly aimed at establishing sustained release of anti-cancer agents such as paclitaxel. Significantly improved bioavailability of the agents and reduced toxicity are afford...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/00 - 07/31/01

Vascular occlusions secondary to thrombi (blood clots) are predisposing factors to strokes, myocardial infarctions, and vascular thrombosis. Mortality for strokes and heart attacks in the United States number 3.4 million annually while morbidity associated with these diseases results in paralysis and loss of motor and cognitive functions. Clearl...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 08/01/99 - 07/31/00
PI: Qiu Wu

Vascular occlusions secondary to thrombi (blood clots) are predisposing factors to strokes, myocardial infarctions, and vascular thrombosis. Mortality for strokes and heart attacks in the United States number 3.4 million annually while morbidity associated with these diseases results in paralysis and loss of motor and cognitive functions. Clearl...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/01/98 - 07/31/98
PI: Qiu Wu

DESCRIPTION (Adapted from applicant's abstract): Vascular occlusions involving thrombi are the major predisposing factor in the origin of myocardial infarction, strokes, and phlebitis. Diseases characterized by vascular clots account for up to fifty percent of adult mortality and enormous expense in hos...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/94 - 09/29/95

DESCRIPTION (Adapted from Applicant's Abstract): Diagnostic ultrasound potentially represents a billion dollar a year market worldwide. The applicants' specific aims and longterm objective involve the development of an efficient and low-cost ultrasound contrast agent with improved image sensitivity such ...

Load More